This is a prospective descriptive and pharmacokinetic study will be conducted among newly
diagnosed patients registered in the two SMRU TB clinics located on the Thai-Myanmar border.
This study aims to recruit (1) 30 adults with HIV co-infection and (2) 30 adults without HIV
co-infection in one year. Patients will be given the standard 6 month anti-TB drugs as per
WHO guidelines.